Comparator / RLD Sourcing, Orphan Drugs
Ancillary Supplies, Specialty Lines , Limited Distribution Drugs
REMS Access, Name Patient Drug Supply
Sourcing Drugs which are difficult to source across Global Market
NEW LIFE MEDICALS (USA), INC.
Raleigh, North Carolina (NC), United States
Healthcare
People
Anika Upadhyay
New Life Medicals (USA), Inc.
Assistant Manager - Bussiness Development (Exports)
Ankit Shah
New Life Medicals (USA), Inc.
Director
Chirag Patel
New Life Medicals (USA), Inc.
General Manager - Operations
Devangi Agarwal
New Life Medicals (USA), Inc.
Business Development - Executive
Het Shah
New Life Medicals (USA), Inc.
Business Development - Executive
About
NEWLIFE MEDICALS IS ONE STOP SOLUTION FOR ALL YOUR PHARMACEUTICAL NEEDS.
NewLife Medicals is the preferred partner in strengthening supply chain for Innovation and R&D in Pharmaceuticals. As a dedicated pharma raw material supplier, we play a pivotal role in providing essential components for the advancement of pharmaceutical research. It is actively engaged in sourcing Reference Listed Drugs, Orphan Drugs, Ancillary Supplies, Active Pharmaceutical Ingredients (API’s) and Finished Dosage Formulations (FDF) in various countries across the globe. This has been made possible by maintaining a relationship of complete Trust, Transparency, and Highest Integrity.
The business is focused around three strategic priorities which strive to incrementally grow, strike strategic collaborations and enrich financial health. These priorities are expand & grow global business, deliver products to enable scientific research and co-exist with healthy partnerships.
Conducting business responsibly and ensuring our values, culture enable decision-making, that helps us meet the expectations of all stakeholders.
NewLife Medicals is the preferred partner in strengthening supply chain for Innovation and R&D in Pharmaceuticals. As a dedicated pharma raw material supplier, we play a pivotal role in providing essential components for the advancement of pharmaceutical research. It is actively engaged in sourcing Reference Listed Drugs, Orphan Drugs, Ancillary Supplies, Active Pharmaceutical Ingredients (API’s) and Finished Dosage Formulations (FDF) in various countries across the globe. This has been made possible by maintaining a relationship of complete Trust, Transparency, and Highest Integrity.
The business is focused around three strategic priorities which strive to incrementally grow, strike strategic collaborations and enrich financial health. These priorities are expand & grow global business, deliver products to enable scientific research and co-exist with healthy partnerships.
Conducting business responsibly and ensuring our values, culture enable decision-making, that helps us meet the expectations of all stakeholders.
